Aurore Perrot

84PUBLICATIONS
215CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyHaematological tumoursNgā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (84)

|Oct 20, 2026
Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy.

|Sep 29, 2026
BCMA Targeted Therapies and Their Impact on Outcomes in Relapsed or Refractory Multiple Myeloma: Results From the French EMMY Cohort.

|Sep 25, 2026
Daratumumab Plus Bortezomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma: Transplant-Ineligible Subgroup Analysis of CEPHEUS.

|Aug 24, 2026
Daratumumab, lenalidomide, and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: MAIA final survival analysis.

|Aug 17, 2026
Blood-based MALDI-TOF mass spectrometry versus bone marrow MRD for monitoring multiple myeloma: CASSIOPEIA study results.

|Jul 02, 2026
Expression profile of CASSIOPEIA patients refines prognostic value of MRD negativity in multiple myeloma.

Pageof 14

Frequent Collaborators

33 joint publications

Jill Corre

25 joint publications

Xavier P Leleu

15 joint publications

Philippe Moreau

10 joint publications

Mohamad Mohty